rs11797

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 2P and 17B. PP3_ModerateBP6_Very_StrongBP7BA1

The NM_033629.6(TREX1):​c.531T>C​(p.Tyr177Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.584 in 1,613,772 control chromosomes in the GnomAD database, including 278,001 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.63 ( 30605 hom., cov: 33)
Exomes 𝑓: 0.58 ( 247396 hom. )

Consequence

TREX1
NM_033629.6 synonymous

Scores

1

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.41

Publications

66 publications found
Variant links:
Genes affected
TREX1 (HGNC:12269): (three prime repair exonuclease 1) This gene encodes a nuclear protein with 3' exonuclease activity. The encoded protein may play a role in DNA repair and serve as a proofreading function for DNA polymerase. Mutations in this gene result in Aicardi-Goutieres syndrome, chilblain lupus, Cree encephalitis, and other diseases of the immune system. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2012]
ATRIP (HGNC:33499): (ATR interacting protein) This gene encodes an essential component of the DNA damage checkpoint. The encoded protein binds to single-stranded DNA coated with replication protein A. The protein also interacts with the ataxia telangiectasia and Rad3 related protein kinase, resulting in its accumulation at intranuclear foci induced by DNA damage. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2012]
ATRIP Gene-Disease associations (from GenCC):
  • breast cancer
    Inheritance: AD Classification: MODERATE Submitted by: G2P
  • Seckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PP3
BayesDel_noAF computational evidence supports a deleterious effect, 0.49
BP6
Variant 3-48467186-T-C is Benign according to our data. Variant chr3-48467186-T-C is described in ClinVar as Benign. ClinVar VariationId is 467831.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.41 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.72 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TREX1NM_033629.6 linkc.531T>C p.Tyr177Tyr synonymous_variant Exon 2 of 2 ENST00000625293.3 NP_338599.1 Q9NSU2-3
ATRIPNM_130384.3 linkc.*1632T>C 3_prime_UTR_variant Exon 13 of 13 ENST00000320211.10 NP_569055.1 Q8WXE1-1A0A024R2U4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TREX1ENST00000625293.3 linkc.531T>C p.Tyr177Tyr synonymous_variant Exon 2 of 2 6 NM_033629.6 ENSP00000486676.2 Q9NSU2-3
ATRIPENST00000320211.10 linkc.*1632T>C 3_prime_UTR_variant Exon 13 of 13 1 NM_130384.3 ENSP00000323099.3 Q8WXE1-1

Frequencies

GnomAD3 genomes
AF:
0.631
AC:
95883
AN:
151970
Hom.:
30557
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.726
Gnomad AMI
AF:
0.579
Gnomad AMR
AF:
0.692
Gnomad ASJ
AF:
0.551
Gnomad EAS
AF:
0.701
Gnomad SAS
AF:
0.684
Gnomad FIN
AF:
0.615
Gnomad MID
AF:
0.608
Gnomad NFE
AF:
0.557
Gnomad OTH
AF:
0.638
GnomAD4 exome
AF:
0.579
AC:
845703
AN:
1461682
Hom.:
247396
Cov.:
105
AF XY:
0.580
AC XY:
421415
AN XY:
727132
show subpopulations
African (AFR)
AF:
0.737
AC:
24661
AN:
33480
American (AMR)
AF:
0.769
AC:
34395
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.553
AC:
14454
AN:
26136
East Asian (EAS)
AF:
0.672
AC:
26693
AN:
39700
South Asian (SAS)
AF:
0.674
AC:
58161
AN:
86258
European-Finnish (FIN)
AF:
0.615
AC:
32767
AN:
53240
Middle Eastern (MID)
AF:
0.653
AC:
3767
AN:
5768
European-Non Finnish (NFE)
AF:
0.553
AC:
615109
AN:
1111990
Other (OTH)
AF:
0.591
AC:
35696
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
30370
60740
91111
121481
151851
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17452
34904
52356
69808
87260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.631
AC:
95992
AN:
152090
Hom.:
30605
Cov.:
33
AF XY:
0.636
AC XY:
47291
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.727
AC:
30154
AN:
41496
American (AMR)
AF:
0.693
AC:
10583
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.551
AC:
1912
AN:
3470
East Asian (EAS)
AF:
0.701
AC:
3627
AN:
5174
South Asian (SAS)
AF:
0.684
AC:
3303
AN:
4832
European-Finnish (FIN)
AF:
0.615
AC:
6508
AN:
10576
Middle Eastern (MID)
AF:
0.622
AC:
183
AN:
294
European-Non Finnish (NFE)
AF:
0.557
AC:
37858
AN:
67942
Other (OTH)
AF:
0.633
AC:
1336
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1877
3754
5631
7508
9385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
782
1564
2346
3128
3910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.592
Hom.:
25746
Bravo
AF:
0.641

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 91% of patients studied by a panel of primary immunodeficiencies. Number of patients: 87. Only high quality variants are reported. -

Chilblain lupus 1;C0796126:Aicardi-Goutieres syndrome 1;C1860518:Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Pathogenic
0.49
CADD
Benign
9.0
PhyloP100
1.4

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11797; hg19: chr3-48508585; API